IBDXvsIJH
iShares iBonds Dec 2032 Term Corporate ETF against iShares Core S&P Mid-Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBDX | IJH | |
|---|---|---|
| Expense ratio | 0.10% | 0.050% |
| Assets | $1.7B | $120.9B |
| Net flow, 1 month | +$24M | +$1.5B |
| Net flow, 1 year | +$551M | +$10.9B |
| Return, YTD | -6.1% | +11.2% |
| Return, 1 year | -6.3% | +11.6% |
| Avg daily volume | 389K | 7.5M |
| Holdings | 318 | 415 |
| Listed | Jun 28, 2022 | May 22, 2000 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS